The effects of various leukocyte filtration strategies in cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 4, 2007, Pages 665-676

  Warren, Oliver ^a   Alexiou, Christos ^b   Massey, Rachel ^a   Leff, Daniel ^a   Purkayastha, Sanjay ^a   Kinross, James ^a   Darzi, Ara ^a   Athanasiou, Thanos ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Cardiac; Cardiopulmonary bypass (CPB); Inflammation; Leukocytes

Indexed keywords

AORTA VALVE REPLACEMENT; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CELL SEPARATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DATA ANALYSIS; DATA BASE; HEART FUNCTION; HEART SURGERY; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; INFECTION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; LEUKOPENIA; LUNG FUNCTION; LUNG INJURY; MITRAL VALVE REPLACEMENT; MORTALITY; OPEN HEART SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STROKE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CELL ADHESION; CEREBROVASCULAR ACCIDENT; HEART; HEART ARREST, INDUCED; HUMANS; KIDNEY; LEUKOCYTE COUNT; LEUKOCYTE REDUCTION PROCEDURES; LEUKOCYTES; LUNG; MYOCARDIAL REPERFUSION INJURY; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 33947101663     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.12.034     Document Type: Review

References (92)

1. Cremer J., Martin M., Redl H., Bahrami S., Abraham C., Graeter T., Haverich A., Schlag G., and Borst H.G. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 6 (1996) 1714-1720
2. Elgebaly S.A., Houser S.L., el Kerm A.F., Doyle K., Gillies C., and Dalecki K. Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg 57 2 (1994) 391-396
3. Edmunds Jr. L.H. The evolution of cardiopulmonary bypass: lessons to be learned. Perfusion 17 4 (2002) 243-251
4. Edmunds Jr. L.H. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 66 5 Suppl. (1998) S12-S16 discussion S25-18
5. Bando K., Schueler S., Cameron D.E., DeValeria P.A., Hatanaka M., Casale A.S., Zebley M.A., Hutchins G.M., Reitz B.A., and Baumgartner W.A. Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion, and liposomal superoxide dismutase. J Heart Lung Transplant 10 2 (1991) 304-309
6. Bando K., Pillai R., Cameron D.E., Brawn J.D., Winkelstein J.A., Hutchins G.M., Reitz B.A., and Baumgartner W.A. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 99 5 (1990) 873-877
7. Schueler S., De Valeria P.A., Hatanaka M., Cameron D.E., Bando K., Zeebley M., Hutchins G.M., Reitz B.A., and Baumgartner W.A. Successful twenty-four-hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model. J Thorac Cardiovasc Surg 104 1 (1992) 73-82
8. Pillai R., Bando K., Schueler S., Zebly M., Reitz B.A., and Baumgartner W.A. Leukocyte depletion results in excellent heart-lung function after 12 h of storage. Ann Thorac Surg 50 2 (1990) 211-214
9. Palanzo D., Manley N., Montesano R., Yeisley G., and Gordon D. Clinical Evaluation of the LeukoGuard (LG-6) arterial line filter for routine open-heart surgery. Perfusion 8 (1993) 489-496
10. Gu Y.J., de Vries A.J., Vos P., Boonstra P.W., and van Oeveren W. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann Thorac Surg 67 3 (1999) 604-609
11. Sawa Y., Matsuda H., Shimazaki Y., Kaneko M., Nishimura M., Amemiya A., Sakai K., and Nakano S. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 108 6 (1994) 1125-1131
12. Gu Y.J., de Vries A.J., Boonstra P.W., and van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 112 2 (1996) 494-500
13. Morioka K., Muraoka R., Chiba Y., Ihaya A., Kimura T., Noguti H., and Uesaka T. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 111 1 (1996) 45-54
14. Treacher D.F., Sabbato M., Brown K.A., and Gant V. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass. Perfusion 16 Suppl. (2001) 67-73
15. Komai H., Naito Y., Fujiwara K., Takagaki Y., Noguchi Y., and Nishimura Y. The protective effect of a leucocyte removal filter on the lung in open-heart surgery for ventricular septal defect. Perfusion 13 1 (1998) 27-34
16. van de Watering L.M., Hermans J., Houbiers J.G., van den Broek P.J., Bouter H., Boer F., Harvey M.S., Huysmans H.A., and Brand A. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97 6 (1998) 562-568
17. Scholz M., Simon A., Matheis G., Dzemali O., Henrich D., Kleine P., Wimmer-Reinecker G., and Moritz A. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res 51 7 (2002) 363-368
18. Matheis G., Scholz M., Simon A., Henrich D., Wimmer-Greinecker G., and Moritz A. Timing of leukocyte filtration during cardiopulmonary bypass. Perfusion 16 Suppl. (2001) 31-37
19. Alexiou C., Sheppard S., Smith D., Gibbs R., and Haw M.P. Effect of blood temperature on the efficacy of systemic leucodepletion during cardiopulmonary bypass: a prospective randomized clinical study. ASAIO J 51 6 (2005) 802-807
20. Salamonsen R.F., Anderson J., Anderson M., Bailey M., Magrin G., and Rosenfeldt F. Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg 79 6 (2005) 2032-2038
21. Gott J.P. Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation. Perfusion 16 Suppl. (2001) 5-9
22. Matheis G., Scholz M., Gerber J., Abdel-Rahman U., Wimmer-Greinecker G., and Moritz A. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Perfusion 16 1 (2001) 43-49
23. Baksaas S.T., Videm V., Mollnes T.E., Tollofsrud S., Hetland G., Pedersen T., and Svennevig J.L. Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion 13 6 (1998) 429-436
24. Chiba Y., Muraoka R., Ihaya A., Morioka K., Sasaki M., and Uesaka T. Leucocyte depletion and prevention of reperfusion injury during cardiopulmonary bypass: a clinical study. Cardiovasc Surg 1 4 (1993) 350-356
25. Di Salvo C., Louca L.L., Pattichis K., Hooper J., and Walesby R.K. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report. J Cardiovasc Surg (Torino) 37 6 Suppl. 1 (1996) 93-100
26. Smit J.J., de Vries A.J., Gu Y.J., and van Oeveren W. Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfus Sci 20 3 (1999) 151-165
27. Stefanou D.C., Gourlay T., Asimakopoulos G., and Taylor K.M. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion 16 1 (2001) 51-58
28. Gott J.P., Cooper W.A., Schmidt Jr. F.E., Brown III W.M., Wright C.E., Merlino J.D., Fortenberry J.D., Clark W.S., and Guyton R.A. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. Ann Thorac Surg 66 3 (1998) 747-753 discussion 753-744
29. Olivencia-Yurvati A.H., Ferrara C.A., Tierney N., Wallace N., and Mallet R.T. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Perfusion 18 Suppl. 1 (2003) 23-31
30. Whitaker D.C., Stygall J.A., Newman S.P., and Harrison M.J. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies. Perfusion 16 6 (2001) 433-446
31. Morris S.J. Leukocyte reduction in cardiovascular surgery. Perfusion 16 5 (2001) 371-380
32. Ortolano G.A., Aldea G.S., Lilly K., O'Gara P., Alkon J.D., Mader F., Murad T., Altenbern C.P., Tritt C.S., Capetandes A., Gikakis N.S., Wenz B., Shemin R.J., and Downey III F.X. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects. Perfusion 17 Suppl. (2002) 53-62
33. Matheis G., Scholz M., Simon A., Dzemali O., and Moritz A. Leukocyte filtration in cardiac surgery: a review. Perfusion 16 5 (2001) 361-370
34. Martin J., Krause M., Benk C., Lutter G., Siegenthaler M., and Beyersdorf F. Blood cardioplegia filtration. Perfusion 18 Suppl. 1 (2003) 75-80
35. Ohto T., Yamamoto F., and Nakajima N. Evaluation of leukocyte-reducing arterial line filter (LG6) for postoperative lung function, using cardiopulmonary bypass. Jpn J Thorac Cardiovasc Surg 48 5 (2000) 295-300
36. Gourlay T., Fleming J., and Taylor K.M. The effects of pulsatile flow on the leukocyte depleting qualities of the Pall LG6 leukocyte depleting arterial line filter: a laboratory investigation. Perfusion 7 3 (1992) 227-232
37. Gourlay T., Fleming J., and Taylor K.M. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter. Perfusion 7 2 (1992) 131-140
38. Thurlow P.J., Doolan L., Sharp R., Sullivan M., Smith B., and Andersen L.W. Studies of the effect of Pall leucocyte filters LG6 and AV6 in an in vitro simulated extracorporeal circulatory system. Perfusion 10 5 (1995) 291-300
39. Hurst T., Johnson D., Cujec B., Thomson D., Mycyk T., Burbridge B., and Mayers I. Depletion of activated neutrophils by a filter during cardiac valve surgery. Can J Anaesth 44 2 (1997) 131-139
40. Thurlow P.J., Doolan L., Sharp R., Sullivan M., Smith B., and Andersen L.W. Laboratory studies of the effect of Pall extracorporeal leucocyte filters LG6 and AV6 on patients undergoing coronary bypass grafts. Perfusion 11 1 (1996) 29-37
41. Englander R., and Cardarelli M.G. Efficacy of leukocyte filters in the bypass circuit for infants undergoing cardiac operations. Ann Thorac Surg 60 6 Suppl. (1995) S533-S535
42. Lust R.M., Bode A.P., Yang L., Hodges W., and Chitwood Jr. W.R. In-line leukocyte filtration during bypass. Clinical results from a randomized prospective trial. ASAIO J 42 5 (1996) M819-M822
43. Mihaljevic T., Tonz M., von Segesser L.K., Pasic M., Grob P., Fehr J., Seifert B., Turina M., and A clinical study. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. J Thorac Cardiovasc Surg 109 6 (1995) 1138-1145
44. Mair P., Hoermann C., Mair J., Margreiter J., Puschendorf B., and Balogh D. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and oxygen free radical release in patients undergoing aortocoronary bypass surgery. Acta Anaesthesiol Scand 43 4 (1999) 452-457
45. Sahlman A., Ahonen J., Salo J.A., and Ramo O.J. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand 45 5 (2001) 558-563
46. Fabbri A., Manfredi J., Piccin C., Soffiati G., Carta M.R., Gasparotto E., and Nardon G. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion 16 Suppl. (2001) 11-18
47. Whitaker D.C., Newman S.P., Stygall J., Hope-Wynne C., Harrison M.J., and Walesby R.K. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg 25 2 (2004) 267-274
48. Ilmakunnas M., Pesonen E.J., Ahonen J., Ramo J., Siitonen S., and Repo H. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg 129 4 (2005) 851-859
49. Leal-Noval S.R., Amaya R., Herruzo A., Hernandez A., Ordonez A., Marin-Niebla A., and Camacho P. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Ann Thorac Surg 80 4 (2005) 1394-1400
50. Koskenkari J., Rimpilainen J., Biancari F., Surcel H.M., Kaukoranta P., Kiviluoma K., Ala-Kokko T., and Juvonen T. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery. Scand Cardiovasc J 39 6 (2005) 358-368
51. Chen Y.F., Tsai W.C., Lin C.C., Lee C.S., Huang C.H., Pan P.C., Chen M.L., and Huang Y.S. Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings. J Thorac Cardiovasc Surg 123 2 (2002) 218-224
52. Chen Y.F., Tsai W.C., Lin C.C., Tsai L.Y., Lee C.S., Huang C.H., Pan P.C., and Chen M.L. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 78 2 (2004) 634-642 discussion 642-633
53. Alexiou C., Tang A.A., Sheppard S.V., Smith D.C., Gibbs R., Livesey S.A., Monro J.L., and Haw M.P. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study. Eur J Cardiothorac Surg 26 2 (2004) 294-300
54. Hachida M., Hanayama N., Okamura T., Akasawa T., Maeda T., Bonkohara Y., Endo M., Hashimoto A., and Koyanagi H. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J 41 3 (1995) M291-M294
55. Johnson D., Thomson D., Mycyk T., Burbridge B., and Mayers I. Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status. Chest 107 5 (1995) 1253-1259
56. Efstathiou A., Vlachveis M., Tsonis G., Asteri T., Psarakis A., and Fessatidis I.T. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome?. J Cardiovasc Surg (Torino) 44 2 (2003) 197-204
57. Karaiskos T.E., Palatianos G.M., Triantafillou C.D., Kantidakis G.H., Astras G.M., Papadakis E.G., and Vassili M.I. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 78 4 (2004) 1339-1344
58. Patel A.N., Sutton S.W., Livingston S., Patel A., Hunley E.K., Hebeler R.F., Henry III A.C., Hamman B.L., Wood R.E., and Urschel Jr. H.C. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg 186 6 (2003) 636-639 discussion 639-640
59. Allen B.S., Rahman S., Ilbawi M.N., Kronon M., Bolling K.S., Halldorsson A.O., and Feinberg H. Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg 64 5 (1997) 1381-1387 discussion 1387-1388
60. Sheppard S.V., Gibbs R.V., and Smith D.C. Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production?. Perfusion 19 1 (2004) 7-10
61. Alexiou C., Tang A.T., Sheppard S.V., Haw M.P., Gibbs R., and Smith D.C. A prospective randomized study to evaluate the effect of leukodepletion on the rate of alveolar production of exhaled nitric oxide during cardiopulmonary bypass. Ann Thorac Surg 78 6 (2004) 2139-2145 discussion 2145
62. Sheppard S.V., Gibbs R.V., and Smith D.C. Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indices in patients with mild lung dysfunction?. Br J Anaesth 93 6 (2004) 789-792
63. Tang A.T., Alexiou C., Hsu J., Sheppard S.V., Haw M.P., and Ohri S.K. Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg 74 2 (2002) 372-377 discussion 377
64. Pugsley W., Klinger L., Paschalis C., Treasure T., Harrison M., and Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 25 7 (1994) 1393-1399
65. Beyersdorf F., Sarai K., Maul F.D., Wendt T., and Satter P. Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg 102 6 (1991) 856-866
66. Rosenkranz E.R., Okamoto F., Buckberg G.D., Robertson J.M., Vinten-Johansen J., and Bugyi H.I. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J Thorac Cardiovasc Surg 91 3 (1986) 428-435
67. Breda M.A., Drinkwater D.C., Laks H., Bhuta S., Corno A.F., Davtyan H.G., and Chang P. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg 97 5 (1989) 654-665
68. Kawata H., Sawatari K., and Mayer Jr. J.E. Evidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischemia in neonatal lambs. J Thorac Cardiovasc Surg 103 5 (1992) 908-917 discussion 917-908
69. Kofsky E.R., Julia P.L., Buckberg G.D., Quillen J.E., and Acar C. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion. J Thorac Cardiovasc Surg 101 2 (1991) 350-359
70. Murai N., Imazeki T., Shioguchi S., Saitou M., Gon S., Yoshida H., and Hata I. Leukocyte-depleted continuous blood cardioplegia for coronary artery bypass grafting. Jpn Heart J 41 4 (2000) 425-433
71. Ichihara T., Yasuura K., Maseki T., Matsuura A., Miyahara K., Ito T., Kato S., Mizuno S., Tamaki S., and Seki A. The effects of using a leukocyte removal filter during cold blood cardioplegia. Surg Today 24 11 (1994) 966-972
72. Hayashi Y., Sawa Y., Nishimura M., Ichikawa H., Kagisaki K., Ohtake S., and Matsuda H. Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation. Ann Thorac Surg 69 6 (2000) 1914-1919
73. Hayashi Y., Sawa Y., Fukuyama N., Miyamoto Y., Takahashi T., Nakazawa H., and Matsuda H. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 min. J Thorac Cardiovasc Surg 126 6 (2003) 1813-1821
74. Sawa Y., Shimazaki Y., Kadoba K., Masai T., Fukuda H., Ohata T., Taniguchi K., and Matsuda H. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 111 1 (1996) 29-35
75. Pearl J.M., Drinkwater Jr. D.C., Laks H., Stein D.G., Capouya E.R., and Bhuta S. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 52 4 (1992) 298-308
76. Browning P.G., Pullan M., Jackson M., and Rashid A. Leucocyte-depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery. Perfusion 14 5 (1999) 371-377
77. Pala M.G., Paolini G., Paroni R., De Veechi E., Gallorini C., Stefano P.L., Di Credico G., Zuccari M., Galli L., and Agape V. Myocardial protection with and without leukocyte depletion: a comparative study on the oxidative stress. Eur J Cardiothorac Surg 9 12 (1995) 701-706
78. De Vecchi E., Paroni R., Pala M.G., Di Credico G., Agape V., Gobbi C., Bonini P.A., Paolini G., and Grossi A. Role of leucocytes in free radical production during myocardial revascularisation. Heart 77 5 (1997) 449-455
79. Suzuki I., Ogoshi N., Chiba M., Komatsu T., and Moizumi Y. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion 13 3 (1998) 205-210
80. Palatianos G.M., Balentine G., Papadakis E.G., Triantafillou C.D., Vassili M.I., Lidoriki A., Dinopoulos A., and Astras G.M. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg 77 3 (2004) 956-961
81. Hiramatsu Y., Koishizawa T., Matsuzaki K., Enomoto Y., and Sakakibara Y. Leukocyte-depleted blood cardioplegia reduces cardiac troponin T release in patients undergoing coronary artery bypass grafting. Jpn J Thorac Cardiovasc Surg 48 10 (2000) 625-631
82. Pearl J.M., Drinkwater D.C., Laks H., Capouya E.R., and Gates R.N. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial. J Heart Lung Transplant 11 6 (1992) 1082-1092
83. Roth M., Kraus B., Scheffold T., Reuthebuch O., Klovekorn W.P., and Bauer E.P. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg 120 4 (2000) 642-650
84. Baksaas S.T., Flom-Halvorsen H.I., Ovrum E., Videm V., Mollnes T.E., Brosstad F., and Svennevig J.L. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion 14 2 (1999) 107-117
85. Hamada Y., Kawachi K., Nakata T., Kohtani T., Takano S., and Tsunooka N. Antiinflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery. Artif Organs 25 12 (2001) 1004-1008
86. Martens S., Matheis G., Wimmer-Greinecker G., Feuerbach J., Jakob A., Mierdl S., and Moritz A. Heparin coating of the extracorporeal circuit combined with leukocyte filtration reduces coagulation activity, blood loss and blood product substitution. Int J Artif Organs 24 7 (2001) 484-488
87. Olivencia-Yurvati A.H., Wallace W.E., Wallace N., Dimitrijevich D., Knust J.K., Haas L., and Raven P.B. Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation. Perfusion 17 Suppl. (2002) 35-39
88. Olivencia-Yurvati A.H., Wallace N., Ford S., and Mallet R.T. Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection. Perfusion 19 Suppl. 1 (2004) S13-S19
89. Sutton S.W., Patel A.N., Chase V.A., Schmidt L.A., Hunley E.K., Yancey L.W., Hebeler R.F., Cheung E.H., Henry III A.C., Meyers T.P., and Wood R.E. Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement. Perfusion 20 1 (2005) 21-29
90. Samankatiwat P., Samartzis I., Lertsithichai P., Stefanou D., Punjabi P.P., Taylor K.M., and Gourlay T. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies. Perfusion 18 2 (2003) 95-105
91. de Vries A.J., Gu Y.J., Post W.J., Vos P., Stokroos I., Lip H., and van Oeveren W. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion 18 1 (2003) 31-38
92. Kennedy NJ, Sheppard S, Smith D. Leucocyte depleting vs. non-leucocyte depleting filters: a prospective, randomized study, comparing oxygenation indices and time to extubation. Br J Anaesth 1998;80(Suppl. 2):43:A85.